---
title: "MDNA Life Sciences, Inc. (MDLS.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/MDLS.US.md"
symbol: "MDLS.US"
name: "MDNA Life Sciences, Inc."
industry: "Patient Care"
datetime: "2026-05-20T03:03:48.507Z"
locales:
  - [en](https://longbridge.com/en/quote/MDLS.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/MDLS.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/MDLS.US.md)
---

# MDNA Life Sciences, Inc. (MDLS.US)

## Company Overview

MDNA Life Sciences, Inc. engages in the development of molecular tests based on the mitochondrial genome. It focuses on the development and commercial application of mitochondrial DNA based biomarkers for the early detection of prostate, ovarian and lung cancers, and endometriosis. The company was founded by Mark Birch-Machin, Robert Thayer, and Ryan L. Parr in 2001 and is headquartered in West Palm Beach, FL.

| Item | Detail |
|------|--------|
| Industry | Patient Care |
| Exchange | US Market |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: 
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 1970-01-01T00:00:00.000Z

**Overall:  (0.00)**

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| Dividend Yield | 0.00% | - | - | - | - |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/MDLS.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/MDLS.US/norm.md)
- [Related News](https://longbridge.com/en/quote/MDLS.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/MDLS.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**